Ontology in Immunology by Lord P & Hilkens C
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License 
 
 
Newcastle University ePrints - eprint.ncl.ac.uk 
 
Lord P, Hilkens C. Ontology in Immunology. Transplantation 2016 
DOI: http://dx.doi.org/10.1097/TP.0000000000001445 
Copyright: 
The final publication is available at Lippincott Williams & Wilkens via 
http://dx.doi.org/10.1097/TP.0000000000001445 
Date deposited:   
25/08/2016 
Embargo release date: 
22 August 2017  
PRODUCTION TITLE PAGE 
Feature eResources 
Title Ontology in Immunology 
 
Authors  Catharien Hilkens, PhD 
Phillip Lord, PhD 
 
Corr address  –  
please use this 
address for 
correspondence 
catharien.hilkens@newcastle.ac.uk 
phillip.lord@newcastle.ac.uk 
 
Disclosure:  
 
The authors declare no conflicts of interest. 
Special feature: Link library 
Figure is a stock 
image 
Every month use the same figure. It should be centered 
between the columns as laid out on template. 
 
 
Article 
 
Overcoming the barrier of graft rejection by the immune system has always been a 
major concern for the transplantologist. Since the seminal work of Medawar & 
colleagues on acquired immunological tolerance to allogeneic skin transplants in the 
1950s (1), the discovery of functionally distinct immune cell subsets has shaped the field 
of Transplant Immunology. We now have a much better picture of how immune cells are 
involved in graft rejection and how we may prevent this. Paradoxically, the more 
knowledge we gain about the functional properties of immune cells, the more we are 
struggling to define these cells, which hampers further progress in the field. 
 
While we all think we know what the definition of a T-cell is, different researchers will 
consider different aspects to be of importance: they might mention the thymus, cell-
mediated immunity, the T-cell receptor. If you do not believe us, try asking the next five 
immunologists you meet for their definition. As we move to subtypes, these differences 
will turn to disagreements. What evidence should we accept to demonstrate that a cell is 
a naturally occurring or an adaptive regulatory T-cell, or, dare we say, a dendritic cell or 
a macrophage? If we do not agree on this, it is hard to make our science reproducible. 
 
Good definitions are surprisingly hard to make and, in fact, there is an entire discipline 
devoted to it called ‘ontology’. This has become more important in many areas as they 
move toward big data approaches – computers require accurate definitions if they are to 
support science (2). Here, we interpret “ontology” broadly to mean, any attempt to 
organize and standardize the way we describe and represent our knowledge, so 
enabling different scientists to accurately compare their results with each other. 
 
In this article, we will describe several online resources that are useful for the 
readership of Transplantation in organizing or describing their data, and expanding this 
with new knowledge. These resources include minimum information models (MIMs), 
databases and ontologies. 
 
MIMs are reporting guidelines that can be used to ensure that all the critical information 
is available in published data. This increases the transparency and reusability of these 
data. As such, MIMs are an important first step toward standardization of experimental 
procedures. The first MIM in the biomedical field was MIAME - Minimum Information 
About a Microarray Experiment - [A] (3). In the field of immunology, Minimal 
Information About T cell Assays (MIATA)[B] provides a framework for the reporting of 
experiments that measure the characteristics and function of T cells (4). MIATA was 
originally designed for the immunomonitoring field, aiming to increase the quality and 
comparability of T cell biomarker data obtained in clinical trials and studies.  It is also a 
useful resource for the reporting of T cell data from non-clinical research studies. 
Another recent initiative is in the field of tolerance-inducing antigen-presenting cell 
(tolAPC) therapies, which have been developed for the prevention of graft rejection after 
transplantation, or for treatment of autoimmune diseases (5). The Minimum 
Information about Tolerogenic Antigen-Presenting cells (MITAP) reporting guidelines 
[C] are very timely considering a number of tolAPC products are currently being tested 
or have been tested in clinical trials (6). It will facilitate a better comparison of the 
differences and similarities of these therapeutic cells. 
 
A clear example of a standardized nomenclature that facilitates better communication 
between scientists is the numbering of surface molecules on immune cells.  The Human 
Leucocyte Differentiation Antigen (HLDA) workshops have taken place 10 times since 
1980, identifying new cell surface molecules and assigning them a cluster of 
differentiation (CD) number (7). The full list and new entries can be found on the Human 
Cell Differentiation Molecules (HCDM) website [D]. 
 
The Gene Ontology (GO - [E]) is an ontology in the more strict sense of the word: 
classifications that enable searching and description. GO classifies the function of gene 
products at the level of i) molecular activity; ii) biological processes and pathways and 
iii) the cellular components in which they are active (8). Importantly, GO describes gene 
product characteristics in a species-independent manner, facilitating comparisons cross-
species. By providing a controlled vocabulary for gene product attributes, published 
data can be annotated in a standardized and computer-readable way.  
 
Probably more directly relevant is the specialist database, IPD-IMGT/HLA, which 
includes sequence for the human MHC (9) [F]. It is part of the international 
ImMunoGeneTics (IMGT) information system, which is a resource describing 
immunoglobulin and T-cell receptor genes (10) [G]. It includes nucleotide and protein 
sequences, polymorphisms and a database of therapeutic antibodies and fusion proteins. 
In addition to its suite of databases, it also includes many tools accessible through its 
website.  
 
The Immune Epitope DataBase (IEDB) [H] is a significant resource containing data 
extracted manually from 15,000 journal articles published since 1960 (11). Their 
website allows searching for epitopes by name, species or disease. The same team also 
provides a set of tools for epitope prediction from a peptide sequence. 
 
Both the IMGT and IEDB are driven underneath by a number of ontologies. The IMGT 
ontology, for example, provides a standard nomenclature for IG, TR and MHC proteins. 
Likewise, the IEDB uses the MHC restriction ontology [I]. The key problem that this 
addresses is the heterogeneity of naming between different species. The MHC restriction 
ontology builds on resources including the IMGT ontologies, and attempts to harmonize 
and cross-link terminology cross-species (12). 
 
The final problem to be answered is how to find new e-resources. One solution here is to 
read a review article, but an alternative can be found at biosharing.org [J], which is a 
comprehensive resource describing the (many!) MIMs, databases and ontologies that 
exist. 
 
Defining and naming things has always been difficult and has caused controversy in 
many different areas of biology – consider the classic paper “What, if anything, is a 
rabbit?”(13). As we get more complex, with more cell types and more protocols, this is 
becoming a pressing issue for immunology also; the reproducibility crisis may not have 
hit us yet, but (like Brexit) it is looming. Currently ontologies are more often a resource 
for database builders and informaticians than immunology researchers. However, if we 
wish to share, compare and reuse data between different laboratories, we will inevitably 
need to organise and catalogue our data better. They will not solve all the issues of 
reproducibility, but they will at least provide us with a common language, and that is a 
start. 
 
 
Links 
 
[A] http://fged.org/projects/miame/ 
[B] http://miataproject.org/ 
[C] http://w3id.org/ontolink/mitap 
[D] http://www.hcdm.org/ 
[E] http://geneontology.org 
[F] http://www.ebi.ac.uk/ipd/imgt/hla/ 
[G] http://www.imgt.org 
[H] http://www.iedb.org 
[I] http://purl.bioontology.org/ontology/MHC 
[J] https://biosharing.org 
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